title: LL-AF283 antibiotics, cyclic biphenyl peptides.
authors.affiliation: Medical Research Division, Lederle Laboratories, American Cyanamid Co., Pearl River, N.Y. 10965.
authors.forename: C C
authors.initials: CC
authors.lastname: Chang
authors.forename: G O
authors.initials: GO
authors.lastname: Morton
authors.forename: J C
authors.initials: JC
authors.lastname: James
authors.forename: M M
authors.initials: MM
authors.lastname: Siegel
authors.forename: N A
authors.initials: NA
authors.lastname: Kuck
authors.forename: R T
authors.initials: RT
authors.lastname: Testa
authors.forename: D B
authors.initials: DB
authors.lastname: Borders
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D023181:Antimicrobial Cationic Peptides; D001419:Bacteria / Q000187:drug effects; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D004151:Dipeptides / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D005285:Fermentation; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D015394:Molecular Structure; D010455:Peptides; D010456:Peptides, Cyclic / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D012988:Soil Microbiology; D013056:Spectrophotometry, Ultraviolet; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013302:Streptomyces / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D004151:Dipeptides; D010455:Peptides; D010456:Peptides, Cyclic; C047536:biphenomycin A; C069922:LL AF283beta